natural forms of semaglutide (Ozempic, Wegovy, Rybelsus) GLP-1s 101: What the science

There have been substantial insights into the mechanisms regulating muscle size in adults

discusin 249-50

Biological actions of GLP-1, source: reference [1] Biopharma PEG Evolution of GLP 1 GLP-1RAs Currently, there are nine GLP-1RAs approved for marketing worldwide (Table 1), mainly for the treatment of diabetes and obesity, of which tirzepatide is a novel dual GLP-1RA/GIPR agonist

The inclusion of single nucleotide polymorphism (SNPs) of patients own genomes, or at least the use of existing data from genome-wide association studies (GWAS), would allow researchers to use approaches such as Mendelian randomization (MR) to draw conclusions about causality

Eli Lillys Orforglipron a non-peptide, oral GLP-1R agonist has demonstrated up to ~1.8% HbA1c reduction and ~12.4% body-weight loss in Phase 3 trials

Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease